Launching invasive, first-in-human trial
β
Jonathan Kimmelman; Alex John London; Bernard Ravina; Tim Ramsay; Mark Bernstein
π
Article
π
2009
π
John Wiley and Sons
π
English
β 94 KB
## Abstract The decision to initiate invasive, firstβinβhuman trials involving Parkinson's disease presents a vexing ethical challenge. Such studies present significant surgical risks, and high degrees of uncertainty about intervention risks and biological effects. We argue that maintaining a favor